Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1444192/000119312514228010/d732577d20f.htm
January 2023
December 2022
December 2022
November 2022
September 2022
September 2022
August 2022
July 2022
June 2022
May 2022
March 2020
February 2020
February 2020
February 2020
February 2020
February 2020
January 2020
December 2019
November 2019
November 2019
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1444192/000119312514228010/d732577d20f.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Acasti Pharma Inc..
Acasti Pharma Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Acasti Pharma Inc. provided additional information to their SEC Filing as exhibits
Ticker: ACST
CIK: 1444192
Form Type: 20-F Annual Report
Accession Number: 0001193125-14-228010
Submitted to the SEC: Fri Jun 06 2014 9:51:02 AM EST
Accepted by the SEC: Fri Jun 06 2014
Period: Friday, February 28, 2014
Industry: Pharmaceutical Preparations